Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer

Affiliations

01 January 2021

-

doi: 10.1024/0300-9831/a000615


Abstract

Vitamin D deficiency is an emerging risk factor for breast cancer suggesting its role in breast cancer pathogenesis. Recent evidence suggests vitamin D receptor (VDR) expression is a prognosis predictor in breast cancer. We set out to determine the status of VDR expression in histologically characterized breast cancers, and whether common genetic variants modify VDR expression in breast cancer. One-hundred and twenty Kuwaiti female breast cancer fixed tissues were assessed for VDR expression to identify the level and location of its expression by immunohistochemistry. VDR variants (rs731236, rs2228570), and vitamin D binding protein (VDBP) variants (rs4588, rs7041) genotypes were ascertained in breast cancer specimens using Taqman genotyping assays. VDR nuclear expression correlated with low grade tumors (p = 0.01), whereas cytoplasmic expression correlated with lymph node positive tumors (p = 0.03). Absence of VDR expression was a marker for high-grade dedifferentiated tumors (p = 0.01). VDBP rs7041 associated with breast cancer risk (OR 1.92, 95% CI: 1.34 - 2.73; p = 0.0004), and VDR rs2228570 correlated with increased VDR cytoplasmic expression (p < 0.0001). In conclusion, VDR expression is altered in breast cancer confirming its involvement in breast cancer progression. Genetic factors appear to play a role in breast cancer risk, and may modify tumor sensitization to vitamin D.

Keywords: Breast Cancer; Genetic polymorphisms; Vitamin D Binding Protein; Vitamin D Receptor.


Similar articles

Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia.

Ahmed JH, Makonnen E, Fotoohi A, Yimer G, Seifu D, Assefa M, Tigeneh W, Aseffa A, Howe R, Aklillu E.Nutrients. 2019 Jan 29;11(2):289. doi: 10.3390/nu11020289.PMID: 30699973 Free PMC article.

Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.

Raza S, Dhasmana A, Bhatt MLB, Lohani M, Arif JM.Asian Pac J Cancer Prev. 2019 Jan 25;20(1):199-206. doi: 10.31557/APJCP.2019.20.1.199.PMID: 30678432 Free PMC article.

Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.

Song DK, Lee H, Hong YS, Sung YA.BMC Endocr Disord. 2019 Dec 23;19(1):145. doi: 10.1186/s12902-019-0477-x.PMID: 31870342 Free PMC article.

Vitamin D receptor polymorphisms and cancer.

Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S.Adv Exp Med Biol. 2014;810:69-105. doi: 10.1007/978-1-4939-0437-2_5.PMID: 25207361 Review.

The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.

Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J.Anticancer Res. 2009 Sep;29(9):3511-36.PMID: 19667145 Review.


Cited by

J-shaped association between uric acid and breast cancer risk: a prospective case-control study.

Fan K, Sun T, Yin F.J Cancer Res Clin Oncol. 2023 Mar 30. doi: 10.1007/s00432-023-04725-y. Online ahead of print.PMID: 36995406

Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.

Sánchez-Céspedes R, Fernández-Martínez MD, Raya AI, Pineda C, López I, Millán Y.BMC Vet Res. 2021 May 25;17(1):197. doi: 10.1186/s12917-021-02901-1.PMID: 34034728 Free PMC article.

Vitamin D receptor gene polymorphisms and its interactions with environmental factors on renal cell carcinoma risk.

Jianhai T, Jian L, Long Z, Wei W, Shumao Z, Yiming W, Xiaojuan L.Genes Environ. 2021 May 18;43(1):19. doi: 10.1186/s41021-021-00185-3.PMID: 34006324 Free PMC article.

Vitamin D regulation of energy metabolism in cancer.

Sheeley MP, Andolino C, Kiesel VA, Teegarden D.Br J Pharmacol. 2022 Jun;179(12):2890-2905. doi: 10.1111/bph.15424. Epub 2021 Apr 8.PMID: 33651382 Free PMC article. Review.

Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases.

Rozmus D, Ciesielska A, Płomiński J, Grzybowski R, Fiedorowicz E, Kordulewska N, Savelkoul H, Kostyra E, Cieślińska A.Int J Mol Sci. 2020 Oct 22;21(21):7822. doi: 10.3390/ijms21217822.PMID: 33105665 Free PMC article. Review.


KMEL References